For over 30 years, almost all studies of HIV/AIDS epidemics and programs have focused on one key population (KP) in isolation from other KPs. This siloed approach has significantly limited scientific understanding of the fundamental dynamics of HIV/AIDS epidemics, and has led us to miss vital opportunities to prevent new infections. Published and preliminary analyses by this team and others suggest that HIV/AIDS epidemics and programs in one KP may affect epidemics and programs in other KPs. For example, our analyses of the 96 largest US metropolitan statistical areas (MSAs) suggest that HIV prevalence among men who have sex with men (MSM) predicts HIV prevalence among people who inject drugs (PWID), and that HIV prevalence among PWID predicts AIDS incidence among heterosexuals. Studies of sexual networks also suggest that mixing occurs across KPs. Likewise, programs targeting one KP may affect epidemics in other KPs: we have found that the presence of syringe exchange programs predicts later lower AIDS incidence and mortality rates among heterosexuals in these MSAs. A key principle undergirding these findings has been that the HIV/AIDS virus, like many infectious diseases, affects populations, not just individuals and networks. Using this population-level approach, we will pioneer a novel line of high-impact epidemiologic, programmatic, and policy research on whether and how HIV/AIDS epidemics and programs affect one another across three KPs (i.e., MSM, PWID, and heterosexuals) in the US. This longitudinal (1992-2015) cohort study of the 96 largest MSAs in the US will (1) create MSA-level annual estimates of HIV/AIDS epidemic outcomes for each KP and KP subgroup (defined by race/ethnicity, age, and, for heterosexuals and PWID, gender), and of HIV/AIDS- related program presence and coverage for these KPs and KP subgroups. It will then describe how each of these epidemiologic and program variables varies across time and MSAs. Using these epidemiologic and programmatic estimates, it will (2) determine if and how HIV/AIDS epidemics in one KP affect and are affected by epidemics in other KPs, both overall and across KP subgroups;and (3) discover determinants of the presence and coverage of HIV/AIDS-related program presence and coverage for each KP and KP subgroup.
Aim 2 will be guided by the Political Ecology of Disease and the Dialectical Model of Epidemics frameworks;
Aim 3 will be guided by the related Theory of Community Action. By achieving these aims and embracing a population-level perspective, the proposed study will advance a new paradigm of research that will discover and describe how cross-KP dynamics help drive HIV/AIDS epidemics in the US. Findings will also open up new arenas for intervention, including interventions that seek to prevent epidemics in one KP from affecting epidemics in other KPs, and that maximize positive effects of interventions across KPs. A team of researchers with deep knowledge of epidemics and programs within each KP has joined forces to integrate their KP- specific expertise to conceptualize and study these cross-KP interactions.
For over 30 years almost all studies of the determinants of HIV/AIDS infection, and most studies of HIV/AIDS progression and outcomes, have focused on one key population (e.g., injectors, men who have sex with men, or heterosexuals) in isolation from other key populations. Our and others'research, however, suggests that HIV/AIDS epidemics and programs in these different key populations may affect one another, which means that the prevailing siloed approach is likely to have missed (a) fundamental dynamics of HIV/AIDS epidemics, and (b) vital opportunities to prevent new infections by intervening in cross-key- population dynamics. The proposed study will help foster and guide a new research paradigm about how HIV/AIDS epidemics and programs affect one another across key populations that will (a) identify previously unknown but fundamental dynamics of these epidemics, and (b) open up new arenas for the development of programs and policies that prevent HIV transmission across key populations.
|Tempalski, Barbara; Cooper, Hannah L F; Kelley, Mary E et al. (2018) Identifying Which Place Characteristics are Associated with the Odds of Recent HIV Testing in a Large Sample of People Who Inject Drugs in 19 US Metropolitan Areas. AIDS Behav :|
|Tempalski, Barbara; Cleland, Charles M; Williams, Leslie D et al. (2018) Change and variability in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007. Subst Abuse Treat Prev Policy 13:28|
|Cooper, Hannah L F; West, Brooke; Linton, Sabriya et al. (2016) Contextual Predictors of Injection Drug Use Among Black Adolescents and Adults in US Metropolitan Areas, 1993-2007. Am J Public Health 106:517-26|
|Friedman, Samuel R; Tempalski, Barbara; Brady, Joanne E et al. (2016) Income inequality, drug-related arrests, and the health of people who inject drugs: Reflections on seventeen years of research. Int J Drug Policy 32:11-6|
|West, Brooke S; Pouget, Enrique R; Tempalski, Barbara et al. (2015) Female and male differences in AIDS diagnosis rates among people who inject drugs in large U.S. metro areas from 1993 to 2007. Ann Epidemiol 25:218-25|
|Friedman, Samuel R; Perlman, David C; Ompad, Danielle C (2015) The Flawed Reliance on Randomized Controlled Trials in Studies of HIV Behavioral Prevention Interventions for People Who Inject Drugs and Other Populations. Subst Use Misuse 50:1117-24|
|Coulter, Robert W S; Blosnich, John R; Bukowski, Leigh A et al. (2015) Differences in alcohol use and alcohol-related problems between transgender- and nontransgender-identified young adults. Drug Alcohol Depend 154:251-9|
|Friedman, Samuel R; Rossi, Diana (2015) Some Musings About Big Events and the Past and Future of Drug Use and of HIV and Other Epidemics. Subst Use Misuse 50:899-902|